Brevan Howard Capital Management’s Monte Rosa Therapeutics GLUE Stock Holding History

Brevan Howard Capital Management’s Portfolio GLUE Stock Details GLUE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell
2025 Q4	$209K	Sell
2025 Q3	$348K	Buy
2025 Q2	$161K	Sell
2025 Q1	$174K	Buy